Thermo Fisher Work with Mitsui Knowledge Industry to Distribute Lipidomics Software
Thermo Fisher Scientific (California, USA) has signed an agreement with Mitsui Knowledge Industry (MKI) (Tokyo, Japan) to be the exclusive distributor of MKI software for interpreting lipidomic research data.
Thermo Fisher Scientific (California, USA) has signed an agreement with Mitsui Knowledge Industry (MKI) (Tokyo, Japan) to be the exclusive distributor of MKI software for interpreting lipidomic research data.
Interest in lipidomics has grown over recent years because of the key roles that lipids play, including energy storage, cell signalling, and supporting cell membrane structure. Studies into the mechanisms of these processes are carried out to increase knowledge of metabolic diseases such as diabetes and hypertension.
"Analysis of lipidomic data requires an enormous amount of energy and time," said Takeshi Bamba, an associate professor in the Department of Biotechnology, Osaka University (Osaka, Japan). “With Lipid Search, we can successfully automate that process, to dramatically enhance performance. By simultaneously analysing more than one million mass spectrometry data, we can uncover many previously unreported lipids."
For more information please visit:
www.thermoscientific.com
Detailed Glycosylation Analysis of Therapeutic Enzymes Utilizing Comprehensive 2D-LC–MS
January 3rd 2025In this article, the use of comprehensive two-dimensional liquid chromatography (LC×LC) coupled to mass spectrometry (MS) for characterizing glycosylation of therapeutic enzymes is presented.
Advancing Gene Therapy: Enzyme Selection for Effective RNA Oligonucleotide Mapping
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), continue to make progress in both primate and first-in-human trials. As this progress builds, the industry remains accountable for characterizing these molecules to meet the requirements of regulatory authorities.
